Previous Page  25 / 29 Next Page
Information
Show Menu
Previous Page 25 / 29 Next Page
Page Background

allied

academies

Allied J Med Res 2017

Volume 1 Issue 2

Herbal Medicine 2017

September 01-02, 2017 London, UK

3

rd

International Conference and Expo on

Herbal & Alternative Medicine

Page 61

Efficacy and safety of Hepano tablet in

liver disorder patients with abnormal liver

function test: a randomized active controlled

prospective clinical study

Satyendra Kumar

Jamia Hamdard University, India

H

epano tablet is anAyurvedic herbal formulation studied

in pre-clinical models for safety and hepatoprotective

efficacy. The current study was a randomized, active

controlled, multicentre, prospective clinical study that

aimed to evaluate hepatoprotective efficacy and safety of

Hepano tablets. Male and female liver diseases patients

(18-65 years) with abnormal liver function tests were

randomized to receive two tablets twice daily orally of

either Hepano or a marketed comparator for 8 weeks

with follow up at day 7, 14, 28 and 56 during treatment

period and thereafter at day 84. Results were assessed

from baseline to end of treatment basis changes in liver

function tests and improvement in clinical symptoms of

icterus in both the groups. Safety was assessed at all the

visits basis changes in laboratory parameters and adverse

event reporting for all cases who took at least one dose of

the study drug. Hepano tablet and marketed comparator

showed significant improvement in Liver functions - serum

aspartate transaminase (AST), alanine transaminase

(ALT) and total, direct and indirect bilirubin levels and

a significant reduction in clinical symptoms of icterus

that was comparable at all the visits. Results concluded

Hepano tablets can significantly improve liver function

tests and clinical symptoms in liver disease patients and

could be consumed safely.

satyendra.kumar@mail.dabur

Allied J Med Res 2017